miR-181c modulates SMAD7 and Parkin in human cardiac fibroblasts: Validation in frail older adults with diabetes and HFpEF

IF 3.5 3区医学 Q2 PHARMACOLOGY & PHARMACY

Vascular pharmacology Pub Date : 2024-06-01 DOI:10.1016/j.vph.2024.107350

Roberta Avvisato , Stanislovas S. Jankauskas , Pasquale Mone , Urna Kansakar , Fahimeh Varzideh , Stefano De Gennaro , Luigi Salemme , Angelo Cioppa , Salvatore Frullone , Gaetano Macina , Marco Di Mauro , Tullio Tesorio , Jessica Gambardella , Gaetano Santulli

引用次数: 0

查看原文本刊更多论文

miR-181c 可调节人心脏成纤维细胞中的 SMAD7 和 Parkin：在患有糖尿病和高频心衰的体弱老年人中进行验证

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Vascular pharmacology 医学-药学

CiteScore

6.60

自引率

2.50%

发文量

153

审稿时长

31 days

期刊介绍： Vascular Pharmacology publishes papers, which contains results of all aspects of biology and pharmacology of the vascular system. Papers are encouraged in basic, translational and clinical aspects of Vascular Biology and Pharmacology, utilizing approaches ranging from molecular biology to integrative physiology. All papers are in English. The Journal publishes review articles which include vascular aspects of thrombosis, inflammation, cell signalling, atherosclerosis, and lipid metabolism.